NVO
Novo Nordisk A/S$43.49
LiveJun 16, 2026
Market cap
$193.24B
52w range
35.12 – 75.78
P / E
—
EPS
—
Volume
2.99M
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Novo Nordisk A/S’s valuation06-03today
- Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know5h
- Novo Nordisk: I Was Fooled By The Market Again (Rating Upgrade)6h
- Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO13h
- Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock?1d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $45.00 (+3.48%)
Candlestick · 1Y
Open in chart workstation →NVO
43.92-42.98%H 78.38L 35.12MA50 42.47MA200 48.42Avg vol 18.2M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.99% | +1.20% | -2.81% | +12.71% | -11.18% | -14.53% | -43.54% | -46.08% | +3.98% | +68.68% | +27078.13% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$43.48
581 sh
Bid
$43.48
400 sh
Ask
$43.50
500 sh
Spread
$0.020
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Industrials+0.85%
- Utilities+0.80%
- Basic Materials+0.69%
- Consumer Cyclical+0.38%
- Energy+0.26%
- Consumer Defensive+0.20%
- Technology+0.08%
- Real Estate-0.02%
- Financial Services-0.59%
- Healthcare-0.88%
- Communication Services-1.16%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General+0.25%
- Solar-4.85%
- Travel Services+2.61%
- Independent Power Producers+2.50%
- Auto - Dealerships+2.19%
- Electronic Gaming & Multimedia+1.81%
- Construction Materials+1.59%
- Steel-1.54%
- Home Improvement+1.53%
- Broadcasting-1.38%
- Engineering & Construction+1.29%
- Business Equipment & Supplies+1.24%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$45.00
+3.48% upside
Low
$45.00
Median
$45.00
High
$45.00
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Knowzacks.com·Jun 16, 2026
- Novo Nordisk: I Was Fooled By The Market Again (Rating Upgrade)seekingalpha.com·Jun 16, 2026
- Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEOreuters.com·Jun 16, 2026
- Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock?zacks.com·Jun 15, 2026
- NVO DCF Analysis: Intrinsic Value $90 vs Price $44gurufocus.com·Jun 15, 2026
- Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry Aboutfool.com·Jun 12, 2026
- Novo Nordisk Stock Up as UK Wegovy Pill Nod Eclipses Security Breachzacks.com·Jun 12, 2026
- Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Knowzacks.com·Jun 11, 2026
Peers
No peer list available for NVO.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|